Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 470

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 470
---
 the Company submitted in response to the September 4, 2024 deficiency letter (the “Warrant Letter”) was not accepted as the Company had provided insufficient evidence to demonstrate that it can effect the Compliance Plan by its 36 -monthexpiration date of December 6, 2024, at which time the Company’s securities will be delisted from Nasdaq, irrespective of the Company’s progress or lack thereof toward regaining compliance with the Rule, and that the Staff had determined to initiate procedures to delist the Company’s warrants from Nasdaq due to the Company’s non -compliance. F-8 NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS
September 30, 2024 NOTE 1. DESCRIPTION OF ORGANIZATION, AND BUSINESS OPERATIONS AND GOING CONCERN (cont.) Pursuant to the Notice, unless the Company requests a hearing to appeal this determination by November 5, 2024, the Company’s warrants and units will be suspended at the opening of business on November 5, 2024, and a Form 25 -NSEwill be filed with the SEC, which will remove the Company’s warrants and units from listing and registration on Nasdaq (the “Warrant/Unit Delisting”). The Company does not intend to request a hearing. The Warrant/Unit Delisting does not affect the listing or trading of the Company’s Class A ordinary shares on the Nasdaq Global Market, other than those contained within the units. As of the date of this Quarterly Report on Form 10 -Q, our warrants and units have been suspended from trading; however, Nasdaq has not yet filed the Form 25 -NSEwith the SEC. First, Second and Third Extensions On February 27, 2023, the Company held an extraordinary general meeting (the “February 2023 EGM”) and its shareholders approved an amendment to its amended and restated memorandum and articles of association (as amended, the “Articles of Association”) and to the investment management trust agreement dated as of September 7, 2021 (as amended, the “Trust Agreement”) to change the payment required to extend the combination period by two three -monthperiods (the “February Extension Amendment Amendment”). In connection with such vote, the holders of 10,693,417 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $111,346,281. Following such redemptions, approximately $68,